Resumo
Definição
História e exame físico
Principais fatores diagnósticos
- high remittent fever
- headache
- myalgia
- conjunctival suffusion
- muscle tenderness
Outros fatores diagnósticos
- chills or rigors
- abdominal pain
- nausea or vomiting
- diarrhea
- asthenia
- anorexia
- photophobia
- eye pain
- neck stiffness
- cough
- dyspnea
- chest pain
- hemoptysis
- oliguria or polyuria
- cardiac arrhythmias
- lymphadenopathy
- splenomegaly
- hepatomegaly
- jaundice
- adenopathy
- mental status changes
- morbilliform rash
Fatores de risco
- contact (direct or indirect) with urine of infected animals
- residence in or travel to an endemic area
- residence in or travel to an area with recent flooding
- involvement in water sports
- poor living conditions/lack of sanitation
Investigações diagnósticas
Primeiras investigações a serem solicitadas
- CBC and differential
- urinalysis
- microscopic agglutination test (MAT)
- enzyme-linked immunosorbent assay (ELISA)
- polymerase chain reaction (PCR)
- darkfield examination
- blood culture
- cerebrospinal fluid (CSF) culture
- ECG
- chest x-ray
- LFTs
- conjugated bilirubin
- metabolic profile
- serum pancreatic enzymes
- CSF analysis
Investigações a serem consideradas
- urine culture
- renal biopsy
- lung biopsy
- staining methods
- latex agglutination
- western blot
- quantitative PCR
Novos exames
- lateral flow assays
- cytokines
Algoritmo de tratamento
mild disease
moderate to severe disease
Colaboradores
Autores
John Fournier, MD
Clinical Fellow
Infectious Disease Section
Yale School of Medicine
New Haven
CT
Declarações
JF declares that he has no competing interests.
Albert I. Ko, MD
Professor of Epidemiology and Medicine
Department Chair
Epidemiology of Microbial Diseases
Yale School of Public Health
New Haven
CT
Declarações
AIK serves as an expert panel member for the Reckitt Global Hygiene Institute and a Board of Directors member for the American Society of Tropical Medicine. He has received grants from Zoetis and has patents which have been awarded and submitted for use in developing diagnostics and vaccines for leptospirosis.
Agradecimentos
Dr John Fournier and Dr Albert I. Ko would like to gratefully acknowledge Dr Nilmarie Guzman, a previous contributor to this topic.
Declarações
NG declares that she has no competing interests.
Revisores
Carmen Isache, MD
Assistant Professor of Medicine
Infectious Disease Division
University of Florida College of Medicine
Jacksonville
FL
Declarações
CI declares that she has no competing interests.
Andreas Jansen, MD, DTM
Scientific Officer
Robert Koch Institute
Department for Infectious Disease Epidemiology
Gastrointestinal Infections
Zoonoses and Tropical Infections Unit
Berlin
Germany
Declarações
AJ declares that he has no competing interests.
Sean V. Shadomy, DVM, MPH
Epidemiologist
Bacterial Zoonoses Branch
DFBMD/NCZVED/CCID
Centers for Disease Control and Prevention
Atlanta
GA
Declarações
SVS declares that he has no competing interests.
Referências
Principais artigos
Levett P. Leptospirosis. In: Mandell, Douglas, and Bennett's principles and practice of infectious diseases. 6th ed. Philadelphia, PA: Churchill Livingstone; 2006:2495-500.
Vijayachari P, Sugunan AP, Shriram AN. Leptospirosis: an emerging global, public health problem. J Biosci. 2008 Nov;33(4):557-69. Resumo
World Health Organization. Human leptospirosis: guidance for diagnosis, surveillance and control. Geneva: World Health Organization; 2003.Texto completo
Centers for Disease Control and Prevention: National Notifiable Diseases Surveillance System (NNDSS). Leptospirosis (Leptospira interrogans) 2013 case definition. Apr 2021 [internet publication].Texto completo
Artigos de referência
Uma lista completa das fontes referenciadas neste tópico está disponível para os usuários com acesso total ao BMJ Best Practice.
Differentials
- Hantavirus cardiopulmonary syndrome
- Dengue fever
- Malaria infection
Mais DifferentialsGuidelines
- CDC Yellow Book: health information for international travel - leptospirosis
- Fever in returned travellers presenting in the United Kingdom: recommendations for investigation and initial management
Mais GuidelinesLog in or subscribe to access all of BMJ Best Practice
Use of this content is subject to our disclaimer